Sigyn Therapeutics SIGY
OTC SIGY
$0.03 +0.00 (+0.00%)
At close: Nov 12, 2026 · 4:00 PM EST

Sigyn Therapeutics (SIGY) EBIT (2014 - 2025)

Updated

Sigyn Therapeutics (SIGY) posted EBIT of -$386,529 for Q3 2025, compared with -$808,458 a year earlier.

Analysis

Sigyn Therapeutics (SIGY) EBIT (2014 - 2025) Analysis & Trends

For the trailing twelve months through Sep 30, 2025, EBIT at Sigyn Therapeutics was -$1.88 million; for FY2024, it came in at -$2.52 million.

  • In prior years, Sigyn Therapeutics' EBIT was -$2.46 million in FY2023, -$2.15 million in FY2022, -$2.01 million in FY2021 and -$916,434 in FY2020.
  • The Q3 2025 figure stands as the highest quarterly EBIT since Q4 2020.
  • According to Business Quant data, EBIT for the three prior quarters was -$469,513 (Q2 2025), -$546,059 (Q1 2025) and -$478,010 (Q4 2024).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -386,529.00
Jun 30, 2025 -469,513.00
Mar 31, 2025 -546,059.00
Dec 31, 2024 -478,010.00
Sep 30, 2024 -808,458.00
Jun 30, 2024 -602,805.00
Mar 31, 2024 -629,972.00
Dec 31, 2023 -717,236.00
Sep 30, 2023 -642,814.00
Jun 30, 2023 -574,009.00
Mar 31, 2023 -521,258.00
Dec 31, 2022 -471,588.00
Sep 30, 2022 -533,647.00
Jun 30, 2022 -532,795.00
Mar 31, 2022 -609,236.00
Dec 31, 2021 -590,939.00
Sep 30, 2021 -573,363.00
Jun 30, 2021 -441,818.00
Mar 31, 2021 -402,096.00
Dec 31, 2020 -344,567.00
API Access

Sigyn Therapeutics EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=SIGY&period=max&api_key=YOUR_API_KEY